Patient Education • Peptide Safety

“Peptide therapy” is a broad term. Some peptide-based medications have established FDA-approved indications and well-defined prescribing information. Other peptides promoted for recovery, muscle growth, anti-aging, or wellness may not be FDA-approved for those uses and may have limited human safety or efficacy data.

The specific molecule, indication, formulation, source, route, dose, and quality controls all matter. Peptides should not be treated as one uniform category.

FDA approval applies to a specific drug, formulation, indication, and manufacturing process. A peptide being naturally occurring or biologically active does not mean that a compounded or research version has been shown to be safe and effective for a particular medical use.

For unapproved compounded peptides, clinicians must consider the available evidence as well as product-quality issues, sterility, dosing consistency, immunogenicity, and the limits of human safety data.

BPC-157 is frequently marketed for recovery or injury-related uses, but FDA has identified limited safety information for proposed routes of administration and potential concerns including immunogenicity and peptide-related impurities in compounded products. Similar caution applies when human clinical evidence is sparse.

Marketing claims should not substitute for evidence from appropriately designed human studies.

Useful questions include: What condition is being treated? Is the drug FDA-approved for that use? What human evidence supports the expected benefit? What adverse effects and contraindications are known? Is there a safer or better-studied alternative? How will treatment be monitored? Where is the medication sourced, and what quality standards apply?

See our peptide therapy overview, hormone testing and evaluation, and hormone replacement therapy pages for additional context.

Written and medically reviewed by David Nazarian, M.D., a board-certified internal medicine physician. This article is educational and does not replace individualized medical care.